Plné znění - 2/2008 Sb. m. s.

Xxxxxxxxxxxx xxxxxxxxxxxx xxxx xxxxxxx, že xxx 16. listopadu 2007 bylo xxxxxxxxxx xxxxxxxxx UNESCO, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾, xxxxxxxx xxxxxxxxx nového xxxxx Přílohy I - Xxxxxxx zakázaných látek x metod xxxxxxx.

Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. xxxxx 2008 x tímto xxxx xxxxxxxxx x xxxxxxxx i pro Xxxxxx xxxxxxxxx. Xxxx xxxxxx Přílohy X x platnost xxxxxxxx xxxxxx Xxxxxxx I Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx ve sportu xx xxxxx xxx xxx 2007, xxxxxxxxx xxx x. 59/2007 Xx. x. x.

Xxxxxxxx xxxxx Přílohy X x xxxx xxxxxxx do xxxxxxx xxxxxx se xxxxxxxxx xxxxxxxx.

X1. XXXXXXXXXX LÁTKY

Xxxxxxxxxx xxxxx xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-androstendiol (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-androstendion (5α-androst-1-en-3,17-dion); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; boldion (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; ethylestrenol (19-xxx-17α-xxxxx-4-xx-17-xx); xxxxxxxxxxxxxx; xxxxxxxxxx; furazabol (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); xxxxxxxxx; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); xxxxxxxxxx; klostebol; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-xxxxxxx-5α-xxxxxxxxx-3-xx-17β-xx); xxxxxxxxxxxxxx (17β-hydroxy-17α-metylestra-4,9-dien-3-on); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestr-4-en-3-on); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); methyltestosteron; xxxxxxxxx; xxxxxxxxx; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; oxabolon; xxxxxxxxxx; xxxxxxxxxxx; oxymetolon; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); quinbolon; xxxxxxxxxx; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); trenbolon x xxxxx xxxxx x xxxxxxxx chemickou xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), androstendion (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, DHEA), xxxxxxxxxxx x xxxxxxxxxxx metabolity x xxxxxxx:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (androst-4-en-3β,17β-diol)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-androstan-3β,17β-diol epi-dihydrotestosteron

xxxxxxx-4-xx-3α,17α-xxxx 3α-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17α-xxxx 19-xxxxxxxxxxxxxxxxx

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, xxx xxxx xxxx xxxxxxxxxx androgenní xxxxxxxxxx xxxxxxx přirozeně, xxxx xx mít xx to, xx Xxxxxx xxxxxxxx xxxx Xxxxxxxxx xxxxx x xxxx xxxxxx xxxxxxxxx Xxxxxxxxx laboratorní nález, xxxx se koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx nebo xxxxxxxxxxx x/xxxx xxxx xx xxxxxxxx xxxx xxxxxxxxx poměr xx Xxxxxx Xxxxxxxxx xxxxxxxx xxxxxxxxx od xxxxxxx xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx xxx, že xxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx. Xxxxxx xx xxx xx to, xx Vzorek xxxxxxxx Xxxxxxxxx xxxxx v xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx xxxxxxxxx poměr xx Vzorku Sportovce xxxxxxxx fyziologickým xxxx xxxxxxxxxxxx xxxxxx.

Xxxx xx mít xx xx, xx Vzorek Xxxxxxxxx obsahuje Xxxxxxxxx xxxxx x xxxxxxxxx xxxxxxx Pozitivní laboratorní xxxxx ve xxxxx xxxxxxxxx x xxx xxxxxxxxx xxxxxxxxxxx, pokud xxx xxxxx spolehlivé xxxxxxxxxx xxxxxx (např. XXXX) prokázat, že xx Xxxxxxxx látka xxxxxxxxxx xxxxxx. X xxxxxxx případě není xxxxx xxxxxxxx xxxxx xxxxxxx.

Když xx xxxxxxx xxxxxxxx analýzy xxxxxxxx xxxxxxxxxxx xx xxxxxxx xxxxxx, xxxxx xx normálně vyskytují x lidí a xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx xxxxxx použití Xxxxxxxx látky, jako xxxx. xxxxxxxxx x xxxxxxxxxxx referenčními xxxxxxxxxxx xxxxxxx, xxxx xxxx xxxxxxxxx xxxxxxxxx xxxxx X/X xxxxx než xxxxx (4) ku xxxxx (1) x xxxxx xxxxxxxxxx analytická xxxxxx (např. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx, xxxxxxx příslušná Xxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx výsledků xxxxxxxxxx testů nebo xxxxxxxxxx xxxxxxxxxx testů.

Xx-xx xxxxxxxxxx xxxxxx xxxxx xxxxxxx, xxx xxxxxxxx xxxx laboratoří xxxxxx xxxx neobvyklý x ne xxxx xxxxxxxxx. Xxxxx xxxxxxxxx xxxxxxx, za použití xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. IRMS) xxxxxxxx xxxxx Zakázané xxxxx, xxxx nutné xxxxxxxx xxxxx xxxxxxx, x xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx. Xxxxx xxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (např. XXXX) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx longitudinální xxxxxx Xxxxxxxxx xxx, že xxxx xxxxxxxxxx Xxxxxxxxxxxxxx xxxxxxxxxx x xxxxxxxxxxxxx 3 měsících xxxxxxx xxxxxxxx xxx xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx longitudinální xxxxxx, xxxx xxxxxx xxxx xxxxxxxxx. Xxxxx xxxxxxxxxxxxxx xxxxxx Xxxxxxxxx, xxxxxxxx xxxxxxxxxx xxxxx, xxxx fyziologicky xxxxxxxx, xxxx xx xxx xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxx.

V xxxxxxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x moči trvale xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx xx xxxxxx xxxxxx xxxxxxxxxxxxx (xx/xx). Xxxxx xxxxxxxxx xxxxxx xxxxx nahlásila x xxxxxxx xxxxxxxxxx analytické xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, může xxx provedeno xxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxx (následných xxxxx).

Xxxxx xxxxxxxxx xxxxxxxxx Xxxxxxxxx laboratorní xxxxx 19-xxxxxxxxxxxxxxx, bude xx xx xxxxxxxxx xx xxxxxxx x přesvědčivý xxxxx xxxxxxxxxx xxxxxx Xxxxxxxx xxxxx. V xxxxxxx xxxxxxx není xxxxx xxxxxxxx xxxxx xxxxxxx.

V xxxxxxx, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, xxxx xx xxx xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx.

2. Xxxxxxx anabolické xxxxx, xxxxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), tibolon, xxxxxxx, xxxxxxxxxx, xxx xx s xxxxxxxx xxxxx na ně.

S2. XXXXXXX A PŘÍBUZNÉ XXXXX

Xxxxxxxxxxx xxxxx x xxxxxx uvolňující xxxxxxx jsou xxxxxxxx:

1. Erytropoetin (XXX);

2. Xxxxxxx xxxxxx (xXX), xxxxxxxx xxxxxxx xxxxxxx xxxxxxx (např. XXX-1), xxxxxxxxxx xxxxxxx xxxxxxx (XXX);

3. Xxxxxxxxxxxxx (xxxx. LH, xXX), zakázané jen x xxxx;

4. Xxxxxxxx;

5. Kortikotropiny

x xxxxx xxxxx x podobnou chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx nemůže xxxxxxxx, xx koncentrace byla xxxxxxxxx fyziologickým xx xxxxxxxxxxxx xxxxxx, xxxx xx xxx za xx, xx Vzorek xxxxxxxx Xxxxxxxxx látku (xxx xx xxxxxxx xxxx) v xxxxxxxxx, xxx xxxxxxxxxxx Xxxxxxxx xxxxx nebo jejích xxxxxxxxxx či xxxxxxxxxx x/xxxx xxxxxxxxx xxxxxx xx Vzorku Xxxxxxxxx xxxxxxx xxxxxxxx hodnoty xxxxxxxx xxxxxxxx x xxxx tak, xx xxxxxxxxxxxx xxxxxxxx endogenní xxxxxxxx.

Xxxxx laboratoř xxxxxxxxx, po xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, že Xxxxxx xxxxxxxx Xxxxxxxxx xxxxx x bude xxxxxxx Pozitivní xxxxxxxxxxx xxxxx.

X3. XXXX-2 XXXXXXXX

Xxxxxxx xxxx-2 xxxxxxxx xxxxxx xxxxxx D- x X-xxxxxxx xxxx xxxxxxxx.

Xxxxxxxx xxxx xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxxx, xxx xxxxx xx xxx xxxxxxxx xxxxx xxxxxxx xxxxxxxx xxxxxxxxxxxx výjimky.

I xxxx byla udělena xxxxxxxx forma xxxxxxxxxxxx xxxxxxx, xxxx xxxxx xxxxxxxxxxx (volný xxxx xxxxxxxxxx) xxxxx než 1000 xxxxxxxxx x 1 xxxxxxxxx xxxx xxxxxxxxx za Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxxxx, že xxxxxxxxxx výsledek xxx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx v inhalaci.

X4. XXXXXXXXXXX X MODULÁTORY XXXXXXX

Xxxxxxxxxxx xxxxxxx jsou xxxxxxxx:

1. Inhibitory xxxxxxxx, zahrnující:

2. Xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx receptorů (XXXX), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx:

4. Xxxxx xxxxxxxxxxxx funkce xxxxxxxxxx včetně xxxxxxxxxx xxxxxxxxxx, xxx ne x xxxxxxxx xxxxx xx xx.

X5. XXXXXXXXX A XXXXXXX XXXXXXXXX LÁTKY

Xxxxxxxxx xxxxx xxxx zakázané. Zahrnují:

Xxxxxxxxx*, xxxxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), plasmaexpandery (xxxx. albumin, xxxxxxx, xxxxxxxxxxxxxxxxx) a další xxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Diuretika xxxxxxxx:

Acetazolamid, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), xxxxxxxxxx x další látky x podobnou chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky (kromě xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx).

* Terapeutická xxxxxxx není platná, xxxxx moč Xxxxxxxxx xxxxxxxx xxxxxxxxx xx xxxxxxx x prahovou xxxx podprahovou hladinou xxxx Zakázané xxxxx (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Xxxxxxxx xx xxxxxxxxxxx:

M2. XXXXXXXX X XXXXXXXXX XXXXXXXXXX

X3. XXXXXX DOPING

Xxxxxxxxxxxxxx xxxxxxx xxxxx, xxxx, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx xxxxxxx genů, xxxxx xxxx schopnost xxxxxx xxxxxxxxx výkon, xx xxxxxxxx.

X6. STIMULANCIA

Xxxxxxx xxxxxxxxxxx (xxxxxx obou xxxxxx xxxxxxxxxx optických (X- x X-) xxxxxxx) xxxx xxxxxxxx, x xxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxx xxxxxx xxxxxxxx užití x xxxxxxxxxxx xxxxxxxxxx xx Xxxxxxxxxxxxxx programu xxx xxx 2008.

Xxxxxxxxxxx zahrnují:

Adrafinil, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, benzfetamin, xxxxxxxxxxxxxxx, xxxxxxxxx, cyklazodon, xxxxxxxxxxxxxxxxx, efedrin****, xxxxxxxx, xxxxxxxxx, ethylamfetamin, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, fenetylin, xxxxxxxxxxx, xxxxxxxxxxx, fenkamin, xxxxxxxxxxx, fenprometamin, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, kokain, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxx (D-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, niketamid, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, oxilofrin, parahydroxyamfetamin, xxxxxxx, pentetrazol, p-methylamfetamin, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x další látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxxxxxxxxx neuvedené výslovně xxxx xxxxxxxx x xxxxx xxxxxx xxxx xxxxxxxxxx xx xxxxxxxxxxx xxxxx xxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xxxx všeobecná xxxxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx umožňuje xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxx je x xxx xxxxx xxxxxxxxxxxxxxx, xx xxxx xxxxxxx xxxxxxxx jako xxxxxxxxx xxxxx.

S7. XXXXXXXXX

Následující xxxxxxxxx xxxx xxxxxxxx:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx xxxxxxxx, xxxxxxxxxxx, xxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, marihuana) xxxx xxxxxxxx.

X9. XXXXXXXXXXXXXXXXXXXX

Všechny glukokortikosteroidy xxxxxxxx orálně, xxxxxxxx, xxxxxxxxxx nebo nitrosvalovou xxxxxxxx xxxx xxxxxxxx. Xxxxxx xxxxx xxxxxxxx xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx xxxxxxxx xxxxxxxx (xxxxxxxxxxxx, do xxxxx xxxxxx, xx okolí xxxxxx, xxxxxxxxxx, do xxxx) x xxxxxxxxx xxxxxxxx vyžadují xxxxxxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxxx xxxx xxxxxxxxx.

Xxxxxxx přípravky podávané xx xxxxxx kožní (xxxxxx iontoforézy/fonoforézy), xxxx, xxxxx, oční, potíže xxxxx xxxxxxx xxxxxx, xxxxxxxx xxx a xxxxx nejsou xxxxxxxx x nevyžadují žádnou xxxxx xxxxxxxxxxxx xxxxxxx.

X1. XXXXXXX

Xxxxxxx (xxxxxx) xx zakázaný pouze Xxx soutěži x xxxxxxxxxxxxx sportech. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx xxxxxxxx a/nebo xxxxxxxx krve. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (hematologická xxxxxxx) je xxx xxxxxx xxxxxxxx xxxxxxx x závorkách.

∙ Xxxxxxxxxxxx xxxxx (FIA) (0.10 x/x)

∙ Xxxxxx (WKF) (0.10 x/x)

∙ Letecké xxxxxx x parašutismus (XXX) (0.20 x/x)

∙ Xxxxxxxxxxx (XXXX, XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxxx (XXXX) xxx xxx xxxxxxxxxx xx xxxxxxxx (0.10 x/x)

∙ Motocyklový xxxxx (XXX) (0.10 x/x)

∙ Xxxxx xxxxxxxxxx (XXX) (0.30 x/x)

∙ Kuželky (XXX) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Pokud xxxx xxxxx xxxxxx, xxxx-xxxxxxxxx xxxx zakázány xxxxx Xxx xxxxxxx x následujících xxxxxxxx.

∙ Automobilový sport (XXX)

∙ Xxxxxxxx (XXXX)

∙ Xxxx (XXXX)

∙ Xxxxx (XXX)

∙ Curling (XXX)

∙ Xxxxxxxxxx (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - xxx xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Letecké xxxxxx a xxxxxxxxxxxx (XXX)

∙ Lukostřelba (XXXX, XXX) (xxxxxxxx xxxx Xxxx soutěž)

∙ Lyžování (FIS) - xxxxx xx xxxxxx a xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx U-rampa x "xxx xxx"

∙ Xxxxxxx pětiboj (XXXX) - xxx xxxxxxxxxx xx xxxxxxxx

∙ Xxxxxxxxxxx xxxxx (XXX)

∙ Petanque x xxxxxxx xxxxxx (XXXX, IPC "bowls")

∙ Xxxxxxx (XXXX, XXX) (xxxxxxxx xxxx Xxxx xxxxxx)

∙ Xxxxx motorismus (XXX)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, karvedilol, labetalol, xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxxxx, sotalol, xxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx

"Xxxxxxxxxx látky"* xxxx xxxxxxxxxxx níže:

∙ Všichni Xxxx-2 xxxxxxxx x xxxxxxxx, xxxxx salbutamolu (xxxxxxx xxxx glukuronidu) při xxxxxxxx větším xxx 1000 ng/ml moči x xxxxxxxxxxxx (xxxxxxx xx skupině X 1.2 Ostatní xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, xxxxxxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, p-metylamfetamin, xxxxxxxxxxxx, xxxxxxxxx, norfenefrin, xxxxxxxxx, ortetamin, oxilofrin, xxxxxxxxxxxxxx, xxxxxxxxx, sibutramin, xxxxxxxxxxxxx a xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxx x xxxxxx X6, pro která Xxxxxxxxx xxxxxxx, xx xxxxxxx xxxxxxxx popsané x xxxxxx X6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx xxxxx, které xxxxxxxx umožňuji xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx, xxxxxxx jsou xxxxxxxxx xxxxxxxx x xxxxxxx xxxxxxxxx xxxxxxxxxxx, xxxx x nichž xx xxxxx pravděpodobnost, že xxxxx xxxxxxx zneužity xxxx xxxxxxxxx xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx pravidla xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx za xxxxxxxxxxx, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, že Xxxxxxx xxxxxxxxxx xxxxx xxxxxx zamýšleno xx xxxxxxx xxxxxxxxxxx xxxxxx...".

Xxxxxx xxxxxxx x. 2/2008 Xx. m. x. nabyl xxxxxxxxx xxxx 31.1.2008.

Xxxxxx předpis x. 2/2008 Xx. m. x. byl xxxxxx xxxxxxx předpisem č. 8/2009 Sb. m. s. x xxxxxxxxx xx 7.2.2009.

Znění xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.